APA (7th ed.) Citation

GSY, K., GG, T., G, Y., EK, T., V, A., MB, A., . . . N, K. (2026). Prognostic value of cachexia index in HR +/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors. BMC cancer, 26(1), . https://doi.org/10.1186/s12885-026-16078-z

Chicago Style (17th ed.) Citation

GSY, Keskin, Turgut GG, Yildirim G, Tuzun EK, Aslan V, Aykan MB, Ince S, and Karadurmus N. "Prognostic Value of Cachexia Index in HR +/HER2 - metastatic Breast Cancer Treated with CDK4/6 Inhibitors." BMC Cancer 26, no. 1 (2026). https://doi.org/10.1186/s12885-026-16078-z.

MLA (9th ed.) Citation

GSY, Keskin, et al. "Prognostic Value of Cachexia Index in HR +/HER2 - metastatic Breast Cancer Treated with CDK4/6 Inhibitors." BMC Cancer, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12885-026-16078-z.